1. Home
  2. NRXP vs OPAD Comparison

NRXP vs OPAD Comparison

Compare NRXP & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • OPAD
  • Stock Information
  • Founded
  • NRXP 2015
  • OPAD 2015
  • Country
  • NRXP United States
  • OPAD United States
  • Employees
  • NRXP N/A
  • OPAD N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • OPAD Real Estate
  • Sector
  • NRXP Health Care
  • OPAD Finance
  • Exchange
  • NRXP Nasdaq
  • OPAD Nasdaq
  • Market Cap
  • NRXP 32.6M
  • OPAD 25.3M
  • IPO Year
  • NRXP N/A
  • OPAD N/A
  • Fundamental
  • Price
  • NRXP $3.37
  • OPAD $1.38
  • Analyst Decision
  • NRXP Strong Buy
  • OPAD Hold
  • Analyst Count
  • NRXP 4
  • OPAD 5
  • Target Price
  • NRXP $28.50
  • OPAD $2.38
  • AVG Volume (30 Days)
  • NRXP 284.1K
  • OPAD 118.6K
  • Earning Date
  • NRXP 08-13-2025
  • OPAD 08-04-2025
  • Dividend Yield
  • NRXP N/A
  • OPAD N/A
  • EPS Growth
  • NRXP N/A
  • OPAD N/A
  • EPS
  • NRXP N/A
  • OPAD N/A
  • Revenue
  • NRXP N/A
  • OPAD $794,159,000.00
  • Revenue This Year
  • NRXP N/A
  • OPAD N/A
  • Revenue Next Year
  • NRXP N/A
  • OPAD $40.79
  • P/E Ratio
  • NRXP N/A
  • OPAD N/A
  • Revenue Growth
  • NRXP N/A
  • OPAD N/A
  • 52 Week Low
  • NRXP $1.10
  • OPAD $0.91
  • 52 Week High
  • NRXP $6.01
  • OPAD $5.13
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 58.22
  • OPAD 74.39
  • Support Level
  • NRXP $2.90
  • OPAD $0.91
  • Resistance Level
  • NRXP $3.53
  • OPAD $1.14
  • Average True Range (ATR)
  • NRXP 0.21
  • OPAD 0.10
  • MACD
  • NRXP -0.04
  • OPAD 0.05
  • Stochastic Oscillator
  • NRXP 66.20
  • OPAD 90.38

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.

Share on Social Networks: